Handel Fresenius Medical Care AG & Co KGaA - FME CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.17 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.019277% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | -0.002946% | ||||||||
Gebyr natten over, tid | 21:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | EUR | ||||||||
Margen | 20% | ||||||||
Aktiebørs | Germany | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Fresenius Medical Care AG & Co KGaA ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Tidligere luk* | 38.1 |
Åben* | 38.12 |
1-Års Ændring* | -36.38% |
Dagens Spænd* | 38.12 - 38.82 |
52-Ugers Spænd | 25.95-63.66 |
Gennemsnitlig Volumen (10 dage) | 1.20M |
Gennemsnitlig Volumen (3 måneder) | 17.38M |
Market Cap | 11.19B |
P/E-forhold | 16.61 |
Udestående aktier | 293.41M |
Omsætning | 19.40B |
EPS | 2.30 |
Dividend (Udbytte %) | 2.93655 |
Beta | 0.84 |
Næste indtjeningsopgørelse | May 9, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Mar 29, 2023 | 38.10 | -0.10 | -0.26% | 38.20 | 38.50 | 37.78 |
Mar 28, 2023 | 38.22 | -0.15 | -0.39% | 38.37 | 38.66 | 37.65 |
Mar 27, 2023 | 38.48 | 1.00 | 2.67% | 37.48 | 38.57 | 37.25 |
Mar 24, 2023 | 37.01 | -0.58 | -1.54% | 37.59 | 37.73 | 36.32 |
Mar 23, 2023 | 37.87 | 0.54 | 1.45% | 37.33 | 37.96 | 37.12 |
Mar 22, 2023 | 37.63 | 0.49 | 1.32% | 37.14 | 37.95 | 37.14 |
Mar 21, 2023 | 37.03 | 0.62 | 1.70% | 36.41 | 37.20 | 36.26 |
Mar 20, 2023 | 36.32 | -0.24 | -0.66% | 36.56 | 37.14 | 35.71 |
Mar 17, 2023 | 36.52 | -0.16 | -0.44% | 36.68 | 37.73 | 35.77 |
Mar 16, 2023 | 36.62 | -0.31 | -0.84% | 36.93 | 37.27 | 36.34 |
Mar 15, 2023 | 36.85 | -0.44 | -1.18% | 37.29 | 37.46 | 36.47 |
Mar 14, 2023 | 37.16 | -0.02 | -0.05% | 37.18 | 37.30 | 36.42 |
Mar 13, 2023 | 37.06 | 0.31 | 0.84% | 36.75 | 37.51 | 36.08 |
Mar 10, 2023 | 36.99 | 1.26 | 3.53% | 35.73 | 36.99 | 35.65 |
Mar 9, 2023 | 36.31 | 0.29 | 0.81% | 36.02 | 36.45 | 35.84 |
Mar 8, 2023 | 36.24 | 0.51 | 1.43% | 35.73 | 36.25 | 35.69 |
Mar 7, 2023 | 36.06 | -0.53 | -1.45% | 36.59 | 36.78 | 35.84 |
Mar 6, 2023 | 37.45 | 0.61 | 1.66% | 36.84 | 37.71 | 36.69 |
Mar 3, 2023 | 36.50 | 0.79 | 2.21% | 35.71 | 36.51 | 35.67 |
Mar 2, 2023 | 35.62 | 0.27 | 0.76% | 35.35 | 36.01 | 35.33 |
Fresenius Medical Care AG & Co KGaA Events
Tid (UTC) (UTC) | Land | Begivenhed |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total omsætning | 19398 | 17618.7 | 17859.1 | 17476.6 | 16546.9 |
Omsætning | 19398 | 17618.7 | 17859.1 | 17476.6 | 16546.9 |
Kost af omsætning, Total | 14087.8 | 12541.7 | 12321.6 | 12080.7 | 11392.1 |
Bruttofortjeneste | 5310.25 | 5077.03 | 5537.44 | 5395.85 | 5154.74 |
Totale Driftsudgifter | 17886.3 | 15766.4 | 15554.7 | 15207 | 13509.1 |
Salgs/Generelle/Admin. Udgifter, Total | 3528.86 | 2996.98 | 3102.8 | 2939.13 | 2709.78 |
Forskning & Udvikling | 218.63 | 214.345 | 188.75 | 164.976 | 133.274 |
Depreciation / Amortization | 9.994 | 6.437 | 5.024 | 3.052 | 0.341 |
Renteudgift (Indkomst) - Netto Drift | 29.864 | -26.024 | -115.456 | -73.611 | -65.408 |
Usædvanlig Udgift (Indkomst) | 11.147 | 33.005 | 51.92 | 92.744 | -661.043 |
Driftsindtægter | 1511.76 | 1852.29 | 2304.41 | 2269.56 | 3037.8 |
Renteindkomst (Udgift), Netto Ikke-Drift | -292.476 | -280.429 | -368.019 | -429.444 | -301.062 |
Netto Indkomst Før Skat | 1219.28 | 1571.86 | 1936.39 | 1840.11 | 2736.74 |
Netto Indkomst Efter Skat | 894.325 | 1219.03 | 1435.83 | 1438.5 | 2225.66 |
Minoritetsrente | -220.92 | -249.72 | -271.455 | -238.881 | -243.733 |
Netto Indkomst Før Ekstra Ting | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
Netto Indkomst | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
Fortyndet Netto Indkomst | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
Fortyndet Vægtet Gennemsnit Aktier | 293.246 | 292.945 | 294.056 | 302.691 | 307.275 |
Fortyndet EPS Uden Ekstraordinære Ting | 2.29638 | 3.30884 | 3.95972 | 3.96318 | 6.45 |
Dividends per Share - Common Stock Primary Issue | 1.12 | 1.35 | 1.34 | 1.2 | 1.17 |
Fortyndet Normaliseret EPS | 3.98317 | 3.79414 | 4.71608 | 4.2027 | 4.70044 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Total omsætning | 4996.8 | 5096.17 | 4756.68 | 4548.37 | 4647.02 |
Omsætning | 4996.8 | 5096.17 | 4756.68 | 4548.37 | 4647.02 |
Kost af omsætning, Total | 3649.28 | 3737.58 | 3410.63 | 3290.27 | 3327.86 |
Bruttofortjeneste | 1347.52 | 1358.59 | 1346.05 | 1258.09 | 1319.16 |
Totale Driftsudgifter | 4644.87 | 4624.52 | 4416.17 | 4200.7 | 4197.87 |
Salgs/Generelle/Admin. Udgifter, Total | 954.297 | 989.607 | 969.489 | 871.241 | 823.21 |
Forskning & Udvikling | 59.237 | 58.452 | 53.334 | 47.607 | 65.701 |
Depreciation / Amortization | 2.812 | 3.032 | 2.084 | 2.066 | 2.057 |
Renteudgift (Indkomst) - Netto Drift | -19.257 | -17.448 | -19.367 | -10.487 | -20.961 |
Driftsindtægter | 351.934 | 471.643 | 340.51 | 347.668 | 449.155 |
Renteindkomst (Udgift), Netto Ikke-Drift | -75.315 | -76.485 | -71.579 | -69.097 | -66.712 |
Netto Indkomst Før Skat | 276.619 | 395.158 | 268.931 | 278.571 | 382.443 |
Netto Indkomst Efter Skat | 193.582 | 282.932 | 206.005 | 211.806 | 303.741 |
Minoritetsrente | -54.778 | -52.832 | -58.865 | -54.445 | -75 |
Netto Indkomst Før Ekstra Ting | 138.804 | 230.1 | 147.14 | 157.361 | 228.741 |
Netto Indkomst | 138.804 | 230.1 | 147.14 | 157.361 | 228.741 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 138.804 | 230.1 | 147.14 | 157.361 | 228.741 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 138.804 | 230.1 | 147.14 | 157.361 | 228.741 |
Fortyndet Netto Indkomst | 138.804 | 230.1 | 147.14 | 157.361 | 228.741 |
Fortyndet Vægtet Gennemsnit Aktier | 293.415 | 293.413 | 293.145 | 293.007 | 293 |
Fortyndet EPS Uden Ekstraordinære Ting | 0.47306 | 0.78422 | 0.50194 | 0.53706 | 0.78069 |
Dividends per Share - Common Stock Primary Issue | 1.12 | 0 | 0 | 0 | 1.35 |
Fortyndet Normaliseret EPS | 1.47121 | 0.42868 | 0.70576 | 0.64864 | 1.14933 |
Usædvanlig Udgift (Indkomst) | -1.503 | -146.699 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 7967.24 | 7275.31 | 7165.15 | 7846.89 | 6374.31 |
Likvider og Kortsigtede Investeringer | 1618.02 | 1243.23 | 1141.05 | 2265.14 | 993.574 |
Cash | 925.134 | 746.851 | 768.706 | 831.885 | 620.145 |
Likvider & Lignende | 556.521 | 334.688 | 239.017 | 1313.75 | 357.964 |
Kortsigtede Investeringer | 136.362 | 161.688 | 133.322 | 119.507 | 15.465 |
Totale Tilgodehavender, Netto | 3769.23 | 3579.29 | 3969.26 | 3765.57 | 3696.15 |
Accounts Receivable - Trade, Net | 3409.06 | 3153.04 | 3421.35 | 3337.71 | 3389.33 |
Total Inventory | 2038.01 | 1895.31 | 1663.28 | 1466.8 | 1290.78 |
Prepaid Expenses | 377.907 | 374.081 | 178.474 | 135.729 | 124.162 |
Other Current Assets, Total | 164.07 | 183.398 | 213.086 | 213.646 | 269.64 |
Total Assets | 34366.6 | 31689 | 32934.7 | 26242.3 | 24025.2 |
Property/Plant/Equipment, Total - Net | 8551.47 | 8186.75 | 8515.4 | 3836.01 | 3491.77 |
Property/Plant/Equipment, Total - Gross | 16654.3 | 14830.4 | 14413.4 | 8507.4 | 7655.4 |
Accumulated Depreciation, Total | -8102.86 | -6643.68 | -5897.98 | -4671.39 | -4163.63 |
Goodwill, Net | 14361.6 | 12958.7 | 14017.3 | 12209.6 | 12103.9 |
Intangibles, Net | 1459.39 | 1381.01 | 1426.33 | 681.331 | 683.058 |
Long Term Investments | 786.905 | 761.113 | 696.872 | 649.78 | 647.009 |
Other Long Term Assets, Total | 1239.97 | 1126.12 | 1113.74 | 1018.66 | 725.149 |
Total Current Liabilities | 7257.63 | 6159.64 | 7007.23 | 6268.28 | 5299.89 |
Accounts Payable | 736.069 | 731.993 | 716.526 | 641.271 | 590.493 |
Accrued Expenses | 2225.56 | 2115.75 | 1964.24 | 2056.49 | 2056.18 |
Notes Payable/Short Term Debt | 1255.85 | 79.27 | 1171.85 | 1394.19 | 769.279 |
Current Port. of LT Debt/Capital Leases | 1329.54 | 1617.52 | 2086.16 | 1244.73 | 994.731 |
Other Current Liabilities, Total | 1710.61 | 1615.11 | 1068.46 | 931.597 | 889.211 |
Total Liabilities | 21667.8 | 20474 | 20976.8 | 14483.9 | 14205.1 |
Total Long Term Debt | 10734.8 | 10683.2 | 10524.6 | 5045.52 | 5794.87 |
Long Term Debt | 6646.95 | 6800.1 | 6458.32 | 5018.76 | 5766 |
Capital Lease Obligations | 4087.8 | 3883.13 | 4066.3 | 26.757 | 28.873 |
Deferred Income Tax | 868.452 | 785.886 | 739.702 | 626.521 | 467.54 |
Minority Interest | 1280.25 | 1116.23 | 1269.32 | 1143.55 | 1008.08 |
Other Liabilities, Total | 1526.68 | 1728.96 | 1435.95 | 1399.99 | 1634.72 |
Total Equity | 12698.8 | 11215.1 | 11957.9 | 11758.4 | 9820.1 |
Common Stock | 293.004 | 292.877 | 304.437 | 307.879 | 308.111 |
Additional Paid-In Capital | 2891.28 | 2872.63 | 3607.66 | 3873.34 | 3969.25 |
Retained Earnings (Accumulated Deficit) | 10826.1 | 10254.9 | 9454.86 | 8831.93 | 7137.25 |
Treasury Stock - Common | 0 | -370.502 | -50.993 | -108.931 | |
Other Equity, Total | -1311.64 | -2205.34 | -1038.55 | -1203.75 | -1485.58 |
Total Liabilities & Shareholders’ Equity | 34366.6 | 31689 | 32934.7 | 26242.3 | 24025.2 |
Total Common Shares Outstanding | 293.004 | 292.877 | 298.329 | 306.879 | 306.451 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 8039.39 | 7967.24 | 7998.91 | 7814.68 | 7789.41 |
Likvider og Kortsigtede Investeringer | 1173.34 | 1481.66 | 1561.83 | 1407.96 | 1073.48 |
Likvider & Lignende | 1173.34 | 556.521 | 1561.83 | 1407.96 | 1073.48 |
Totale Tilgodehavender, Netto | 3890.82 | 3571.42 | 3449.86 | 3526.45 | 3894.15 |
Accounts Receivable - Trade, Net | 3707.49 | 3409.06 | 3323.6 | 3419.51 | 3740.71 |
Total Inventory | 2136.96 | 2038.01 | 2119.8 | 2052.94 | 1989.41 |
Other Current Assets, Total | 838.272 | 876.151 | 867.414 | 827.332 | 832.376 |
Total Assets | 34724.1 | 34366.6 | 33830.9 | 32987.2 | 33158.5 |
Property/Plant/Equipment, Total - Net | 8510.45 | 8551.47 | 8391.22 | 8320.06 | 8415.64 |
Goodwill, Net | 14628.7 | 14361.6 | 13901.4 | 13495.5 | 13638.9 |
Intangibles, Net | 1480.42 | 1459.39 | 1418.94 | 1395.03 | 1401.5 |
Long Term Investments | 798.947 | 786.905 | 742.799 | 708.56 | 726.595 |
Other Long Term Assets, Total | 1266.2 | 1239.97 | 1377.62 | 1253.37 | 1186.48 |
Total Current Liabilities | 6377.45 | 7257.63 | 7492.3 | 7424.63 | 7242.97 |
Accounts Payable | 790.236 | 736.069 | 706.385 | 684.981 | 635.422 |
Accrued Expenses | 3515.83 | 3676.88 | 3885.14 | 3850.79 | 3792.75 |
Notes Payable/Short Term Debt | 1115.21 | 1255.85 | 1363.29 | 1385.03 | 1140.62 |
Current Port. of LT Debt/Capital Leases | 730.959 | 1329.54 | 1293.77 | 1261.47 | 1423.64 |
Other Current Liabilities, Total | 225.212 | 259.293 | 243.715 | 242.356 | 250.54 |
Total Liabilities | 21489.6 | 21667.8 | 21601.2 | 21355.3 | 21160.5 |
Total Long Term Debt | 11497.2 | 10734.8 | 10570.1 | 10469 | 10336.2 |
Long Term Debt | 7451.79 | 6646.95 | 6571.22 | 6499 | 6315.27 |
Capital Lease Obligations | 4045.41 | 4087.8 | 3998.86 | 3970.02 | 4020.95 |
Deferred Income Tax | 896.38 | 868.452 | 863.9 | 800.492 | 809.215 |
Minority Interest | 1304.8 | 1280.25 | 1216.24 | 1180.48 | 1201.58 |
Other Liabilities, Total | 1413.8 | 1526.68 | 1458.73 | 1480.62 | 1570.47 |
Total Equity | 13234.5 | 12698.8 | 12229.7 | 11632 | 11998.1 |
Common Stock | 293.027 | 293.004 | 292.994 | 292.979 | 292.888 |
Additional Paid-In Capital | 2891.74 | 2891.28 | 2884.96 | 2886.97 | 2887.04 |
Retained Earnings (Accumulated Deficit) | 11027.2 | 10826.1 | 10567.7 | 10290.6 | 10500 |
Other Equity, Total | -977.445 | -1311.64 | -1515.97 | -1838.63 | -1681.86 |
Total Liabilities & Shareholders’ Equity | 34724.1 | 34366.6 | 33830.9 | 32987.2 | 33158.5 |
Total Common Shares Outstanding | 293.027 | 293.004 | 292.994 | 292.979 | 292.888 |
Cash | 925.134 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netto indkomst/Startlinje | 1219.03 | 1435.83 | 1438.5 | 2225.66 | 1554.53 |
Likvider Fra Driftsaktiviteter | 2489.5 | 4233.16 | 2566.95 | 2061.91 | 2191.81 |
Likvider Fra Driftsaktiviteter | 1623.68 | 1785.9 | 1593.16 | 724.847 | 735.479 |
Deferred Taxes | 67.259 | 111.104 | 64.266 | 89.171 | -203.046 |
Ikke-Likvide Ting | 232.342 | 215.137 | 304.705 | -824.73 | -126.822 |
Cash Taxes Paid | 345.052 | 301.663 | 387.719 | 358.386 | 674.625 |
Likvid Rente Betalt | 341.629 | 379.994 | 470.223 | 311.971 | 339.088 |
Ændringer i Driftskapital | -652.807 | 685.184 | -833.68 | -153.034 | 231.666 |
Likvider fra Investeringsaktiviteter | -1196.23 | -1334.94 | -3285.99 | -245.039 | -991.541 |
Kapitaludgifter | -886.715 | -1085.23 | -1162.76 | -1142.38 | -970.83 |
Andre Investerings-Cash-Flow-Ting, Total | -309.513 | -249.709 | -2123.22 | 897.34 | -20.711 |
Likvider fra Financieringsaktiviteter | -1024.38 | -2664.03 | -466.633 | -681.736 | -798.63 |
Financiering af Cash-Flow-Ting | -279.535 | -693.531 | 153.387 | -528.009 | -185.979 |
Total Cash Dividends Paid | -392.455 | -351.17 | -354.636 | -324.838 | -293.973 |
Udstedelse (Pensionering) af Aktier, Netto | 6.511 | -353.335 | -583.932 | 10.183 | -10.347 |
Udstedelse (Pensionering) af Gæld, Netto | -358.903 | -1265.99 | 318.548 | 160.928 | -308.331 |
Udenlandsk Børs Effekter | 131.228 | -160.371 | 47.76 | 32.387 | -132.413 |
Netto Ændring i Likviditet | 400.116 | 73.816 | -1137.91 | 1167.52 | 269.227 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 211.806 | 1219.03 | 915.287 | 584.052 | 304.334 |
Cash From Operating Activities | 158.697 | 2489.5 | 1820.45 | 1128.77 | 207.648 |
Cash From Operating Activities | 418.957 | 1623.68 | 1186.57 | 783.735 | 388.202 |
Deferred Taxes | -9.295 | 67.259 | -12.828 | -36.814 | -6.054 |
Non-Cash Items | 54.974 | 232.342 | 116.658 | 91.471 | 40.292 |
Cash Taxes Paid | 44.301 | 345.052 | 268.11 | 209.901 | 41.793 |
Cash Interest Paid | 79.484 | 341.629 | 255.162 | 171.384 | 104.607 |
Changes in Working Capital | -517.745 | -652.807 | -385.234 | -293.674 | -519.126 |
Cash From Investing Activities | -211.316 | -1196.23 | -773.438 | -473.178 | -224.053 |
Capital Expenditures | -198.313 | -854.36 | -858.778 | -522.335 | -290.79 |
Other Investing Cash Flow Items, Total | -13.003 | -341.868 | 85.34 | 49.157 | 66.737 |
Cash From Financing Activities | -266.641 | -1024.38 | -666.849 | -378.319 | -35.915 |
Financing Cash Flow Items | 464.211 | -279.535 | -208.996 | -133.871 | -47.907 |
Issuance (Retirement) of Stock, Net | 0.792 | 6.511 | 6.005 | 5.228 | 0.575 |
Issuance (Retirement) of Debt, Net | -731.644 | -358.903 | -71.403 | 142.779 | 11.417 |
Foreign Exchange Effects | 10.947 | 131.228 | 100.131 | 49.146 | 44.259 |
Net Change in Cash | -308.313 | 400.116 | 480.295 | 326.419 | -8.061 |
Total Cash Dividends Paid | -392.455 | -392.455 | -392.455 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
Fresenius SE & Co KGaA | Corporation | 32.1663 | 94380382 | 0 | 2023-02-21 | LOW |
Pzena Investment Management, LLC | Investment Advisor/Hedge Fund | 5.2 | 15257499 | 6433048 | 2023-01-02 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.105 | 12044710 | 1321531 | 2023-03-17 | LOW |
Harris Associates L.P. | Investment Advisor/Hedge Fund | 3.0098 | 8831173 | 15678 | 2023-02-28 | LOW |
Dodge & Cox | Investment Advisor/Hedge Fund | 3.0017 | 8807448 | -5315479 | 2023-01-03 | LOW |
Artisan Partners Limited Partnership | Investment Advisor | 2.9941 | 8785062 | 0 | 2023-01-02 | LOW |
Templeton Investment Counsel, L.L.C. | Investment Advisor/Hedge Fund | 2.659 | 7801761 | 200236 | 2023-01-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.037 | 5976971 | 13981 | 2023-02-28 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.2147 | 3564186 | -379946 | 2022-12-31 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 1.0855 | 3185091 | 105743 | 2023-02-28 | LOW |
Fidelity International | Investment Advisor | 0.9623 | 2823645 | 47140 | 2023-01-31 | LOW |
Lazard Asset Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8519 | 2499677 | -3590 | 2023-02-28 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.5802 | 1702442 | 36990 | 2023-02-28 | LOW |
Macquarie Investment Management | Investment Advisor | 0.5594 | 1641311 | -6380 | 2023-02-28 | LOW |
Deka Investment GmbH | Investment Advisor/Hedge Fund | 0.5432 | 1593946 | 25473 | 2023-02-28 | LOW |
Fiduciary Management, Inc. | Investment Advisor | 0.506 | 1484650 | 130000 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.4893 | 1435667 | 839 | 2023-02-28 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.4514 | 1324441 | 10743 | 2023-02-28 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 0.4436 | 1301694 | 81837 | 2023-02-28 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 0.4212 | 1235851 | 0 | 2023-02-28 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Fresenius Medical Care Company profile
Om Fresenius Medical Care AG & Co KGaA
Fresenius Medical Care AG & Co. KGaA er et tysk nyredialyseinstitut. Selskabet tilbyder dialysebehandling og relaterede tjenester til personer, der lider af nyreinsufficiens i slutstadiet (ESRD), samt andre sundhedstjenester. Selskabet udvikler og fremstiller også en lang række sundhedsplejeprodukter, herunder dialyseprodukter og andre produkter end dialyseprodukter. Selskabets dialyseprodukter omfatter hæmodialysemaskiner, peritonealcyklere, dialysatorer, peritonealopløsninger og -granulater, blodbaner, nyremedicinske lægemidler og systemer til vandbehandling. Dens ikke-dialyseprodukter omfatter akutte kardiopulmonale produkter og produkter til aferese. Selskabet forsyner dialyseklinikker, som det ejer, driver eller administrerer, med en bred vifte af produkter og sælger dialyseprodukter til andre udbydere af dialysetjenester.
Industry: | Healthcare Facilities & Services (NEC) |
Else-Kröner-Straße 1
BAD HOMBURG VOR DER HOHE
HESSEN 61352
DE
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com